Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

T-Cell Therapy Trial Begins for Autoimmune Diseases

A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders. . . . → Read More: T-Cell Therapy Trial Begins for Autoimmune Diseases

Inhaled Drug Shown Feasible for Postpartum Bleeding

Results from a clinical trial show a dry-powder inhaled form of the drug oxytocin works in the body much like the injected form, given to prevent postpartum hemorrhage, excessive bleeding in some women after childbirth. . . . → Read More: Inhaled Drug Shown Feasible for Postpartum Bleeding

Trial to Test Gene Therapy for Inherited Eye Disease

A spin-off enterprise from University of Oxford in the U.K. began enrolling participants in a clinical trial testing gene therapy to correct a genetic eye disease. . . . → Read More: Trial to Test Gene Therapy for Inherited Eye Disease

Trial Shows Bioactive Glass Stops Bone Infections

Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics. . . . → Read More: Trial Shows Bioactive Glass Stops Bone Infections

Trial Underway to Test Cancer Immunotherapy Aid

A clinical trial began recruiting participants with advanced tumors to test a compound that helps treatments for cancer harnessing the immune system. . . . → Read More: Trial Underway to Test Cancer Immunotherapy Aid

Mobile App-Controlled Patch Reduces Migraine Pain

A patch worn on the arm providing stimulation to nerve cells was shown in a clinical trial to reduce the amount of pain experienced by people with migraines. . . . → Read More: Mobile App-Controlled Patch Reduces Migraine Pain

Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma

A clinical trial testing synthetic immune system cells shows after 6 months the cells can generate a full or partial response in many patients with non-Hodgkin lymphoma. . . . → Read More: Engineered T-Cells Shown Reducing Non-Hodgkin Lymphoma

Trial Begins Testing Enhanced Cord Blood Stem Cells

A clinical trial testing transplant grafts derived from umbilical cord blood as an alternative to bone marrow stem cells for people with blood-related cancers is treating its first patient. . . . → Read More: Trial Begins Testing Enhanced Cord Blood Stem Cells

Test of Nasal Skin Cells Found to Detect Lung Cancer

A diagnostic test analyzing the genes in skin cells from nasal passages can detect lung cancer, and the absence of cancer, as accurately as more invasive samples from the airways. . . . → Read More: Test of Nasal Skin Cells Found to Detect Lung Cancer

Biofeedback Device Reduces Panic Attacks in Trial

A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment. . . . → Read More: Biofeedback Device Reduces Panic Attacks in Trial